Depression

Investing in outpatient behavioral health treatment pathways found to be a cost-effective measure to better manage both medical and behavioral conditions.

Prior research has associated early adolescent use of hormonal contraceptives with the risk of depression in adulthood.

Demand for treatment of anxiety and depression remained high for the third consecutive year as the demand for the treatment of trauma- and stressor-related and substance use disorders has increased.

Analysis indicates that a 25-mg dose reduces the condition scores significantly more than a 1mg dose over a 3-week period, but the 10-mg dose did not yield the same results.

With many different classes of medications used in the treatment of major depressive disorder, pharmacists can have a significant impact on patients' lives, from counseling on medications to assisting with finding the right medication.

Systemically administered hormonal therapy may be associated with a greater risk of depression before and during menopause.

Experts discuss the clinical and economic impact of misdiagnosing bipolar I disorder as major depressive disorder.

New research finds that mental health has replaced COVID-19 as the top health concern among Americans, but deeper analysis needs to be done into whether depression and anxiety are truly becoming more widespread.

New research about the risks of dementia in patients with non-affective psychotic disorders could help shape new life course models for prevention.

The research further supports zuranolone as a potential episodic treatment for people with MDD, according to the study authors.

Pregnant women with epilepsy showed more symptoms of anxiety and depression than healthy pregnant or non-pregnant women, but mental health screening may help.

Routine depression screening in the primary care setting lowered screening disparities and increased recognition of symptoms for groups at risk of undertreatment, including racial and ethnic minority individuals and patients of older age.

A systematic review of literature found that family history of psychiatric disorders is a risk factor associated with postpartum depression, adding to a contradictory body of research.

Abbott will work with the FDA to expedite the review of their deep brain stimulation system to treat the life-threatening disease of treatment-resistant depression.

Transgender children were more susceptible to depression, anxiety, and other mental health issues than their cisgender counterparts.

Participants took about 50 times higher than the recommended daily allowance every day for a month, investigators say

A review of decades of research concluded that there is no evidence of an association between serotonin levels and depression, calling the function of antidepressants into question.

Appropriate screening tools can help identify individuals at increased risk for or with anxiety, depression, and eating disorders.

The medications are linked with reduced negative emotional bias, according to new research published in Biological Psychiatry.

More than half of women diagnosed with anxiety and/or depression said they waited at least 1 year before seeking treatment, or never sought treatment at all.

Studies have estimated that 16% of people with dementia experience depression, but this may be as high as 40%, demonstrating a great need for effective treatments.

Larger increases were typically seen in states with fewer deaths related to COVID-19, lower unemployment among women, analysis finds.

The companies expect to complete the submission to the FDA for MDD in the first half of 2022 and an associated filing for postpartum depression in 2023.

Depression can make people who have recovered from COVID-19 feel less enthusiastic in their daily lifestyle.

When states legalize marijuana, the volume of prescriptions within the drug classes that align with the medical indications for pain, depression, anxiety, sleep, psychosis, and seizures significantly decline.